William J Phd Link Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 days, 6 hours ago
William J Phd Link has an estimated net worth of at least $10.2 million*, as of Aug. 20, 2025. They own 170,448 shares of TARS stock. They have sold 613,250 shares of TARS stock since 2021, for an estimated $912,960.
William J Phd Link $TARS SEC Form 4 Insider Trading
William J Phd Link has filed a total of 2 insider trades in $TARS since 2021. Their most recent trade was a sale of 5,021 shares, made on Aug 12, 2024. Their largest trade was a sale of 29,979 shares, made on Aug 12, 2024. We estimate that they now own 170,448 shares of $TARS, worth an estimated $9.3 million.
Insider Trading at $TARS
There have been a total of 198 insider trades reported at $TARS since 2021, with 128,906 shares purchased and 1.5 million shares sold. The most active insider traders in $TARS stock have been Bobak R. Azamian, Bobak R. Azamian, and Aziz Mottiwala. The most recent trade was a sale of 6,000 shares reported by Bobak R. Azamian (President/CEO and Board Chair), made on Aug 11, 2025.
History of Insider Stock Trades by William J Phd Link
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
TARS
|
Sale | 5,021 | Aug 12, 2024 | Aug. 14, 2024, 4:34 p.m. |
|
TARS
|
Sale | 29,979 | Aug 12, 2024 | Aug. 14, 2024, 4:34 p.m. |
RXST
|
Sale | 20,598 | Feb 01, 2024 | Feb. 2, 2024, 5:49 p.m. |
|
RXST
|
Sale | 7,652 | Feb 01, 2024 | Feb. 2, 2024, 5:49 p.m. |
OYST
|
Sale | 1,531 | Oct 18, 2021 | Oct. 19, 2021, 8 p.m. |
|
OYST
|
Sale | 303,614 | Oct 18, 2021 | Oct. 19, 2021, 8 p.m. |
|
OYST
|
Sale | 242,943 | Oct 18, 2021 | Oct. 19, 2021, 8 p.m. |
|
OYST
|
Sale | 1,912 | Oct 18, 2021 | Oct. 19, 2021, 8 p.m. |
|
RXST
|
Purchase | 31,250 | Aug 03, 2021 | Aug. 4, 2021, 8 p.m. |
$TARS Executives and Stock Owners with Insider Trades
-
Bobak R. Azamian, President/CEO and Board Chair
-
Bobak R. Azamian, President and CEO
-
Aziz Mottiwala, Chief Commercial Officer
-
Leonard M. Greenstein, Chief Financial Officer
-
Bryan Wahl, General Counsel
-
Dianne C. Whitfield, Chief Human Resources Officer
-
Seshadri Neervannan, Chief Operating Officer
-
Jose M. Trevejo, CHIEF MEDICAL OFFICER
-
Jeffrey S Farrow, See Remarks
-
Mark J. Holdbrook, V.P., Clinical Affairs
-
Elizabeth Yeu Lin, Chief Medical Officer
-
Jose M. Trevejo, Chief Medical Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.